Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
Clinical trial NCT00048581 · COMPLETED
Trial details
- NCT number
- NCT00048581
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-12-01
- Primary completion
- 2009-09-01
- Enrollment
- 738
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.